Page 1 - Carnot
P. 1
The OPALE Carnot Institute is a preferred partner to the healthcare Industry for
research and development of innovative solutions aimed at diagnostic, treatment
and follow-up of patients with leukemia and related diseases, together the blood
cancer with the highest mortality rate, also the first child cancer. Thanks to its 550
engaged staff, the Institute offers partner companies an easy, quick and efficient
access to internationally unmatched R&D expertise and specialized means for the
acceleration, together, of innovation along the R&D value chain.
www.opale.org
